Name: Too many preventable breast-cancer deaths in LMICs: innovative approaches to improve early diagnosis to reduce mortality
Start: 2024-09-27T08:00:00-0400
End: 2024-09-27T09:30:00-0400

SCIENCE SUMMIT 2024: 17 - 27 September, New York

This Programme exclusively outlines the Science Summit events in New York from September 17th to 27th.
Participation is free of charge, but registration is required.
For those attending in person, please choose the in-person attendance option on the registration form so we can issue your pass.
For virtual attendees, once registered, you can join sessions by clicking at the circular checkbox icon next to each session on the event platform. Please ensure you select the sessions you wish to attend, as failure to do so will prevent access to the live stream.
You can customize your experience by creating your own schedule based on the sessions you are interested in.

Friday September 27, 2024 8:00am - 9:30am EDT

TBA

Video will become available 10 minutes before session start

Globally, a mother, a wife, a daughter, and a sister die every minute from breast cancer. Breast cancer is the leading cause of female cancer death in most of the world. Eighty per cent of this cancer burden is in low- and- middle-income countries (LMICs) where only 5% of the global funding is available. The WHO Global Breast Cancer Initiative has three key pillars to solve the challenges in breast cancer care, including health promotion, early detection, timely diagnosis, and comprehensive breast cancer management. We bring solutions aligned with these pillars and with our initial focus on early detection using ultrasound (US) and artificial intelligence (AI). Artificial intelligence enabled the US to facilitate the implementation of task shifting, thus democratizing access for women at the points of need.

Essential factors to improve care and build health systems include improving women’s agency, equity, and decision power and eliminating barriers to accessing services and interventions. In high-income regions, mammography (MG) is the standard for early detection of breast cancer, yet it has significant limitations in LMICs, first and foremost being lack of access. MG is expensive and requires significant infrastructure (e.g. segregated space, large amounts of electricity, specialized air conditioning, radiation safety measures, regular maintenance and repair, and extensive training). These factors are significant contributors to the fact that most cancers in Sub-Saharan Africa present at late stages (85% in are stages III and IV), mostly too late for cure.

We propose transforming the current breast cancer care model to an accurate, accessible, lower-cost, point-of-need model. We bring hope and solutions for early detection of breast cancer, step one in the continuum of breast cancer.

Speakers

Linda Goler Blount, MPH

Black Women’s Health Imperative

Linda Goler Blount, MPH, is an epidemiologist and President of the Black Women’s Health Imperative, the first national non-profit organization focused on Black women’s health and wellness.Ms. Blount has overseen more than $30 million invested in research to prevent chronic disease... Read More →

Marleen Temmerman (Convenor)

Professor, The Aga Khan University, Kenya

Prof Marleen Temmerman is Director of the Centre of Excellence in Women and Child Health at Aga Khan University East-Africa and Chair of the Department of Obstetrics and Gynaecology at Aga Khan University Hospital Nairobi, Kenya. She has enormous experience in academia and political... Read More →

Dr. James Benedict

Left Tackle Capital and the BeDoWin Institute

James Benedict brings 25+ years of experience in venture capital and private equity. He is a family office investor, human capital partner, and entrepreneur. James is a Co-Founder of both Left Tackle Capital and the BeDoWin Institute, accelerators for high potential venture capital... Read More →

Dr. Miriam Mutebi

Aga Khan University Hospital

Dr. Mutebi is a consultant breast surgical oncologist and assistant professor in the Department of Surgery at the Aga Khan University Hospital in Nairobi, Kenya. She is also a clinical epidemiologist and health systems researcher with a research focus on understanding barriers to... Read More →

Dr. Mary Nyangasi

Technical Officer, Cancer and Lead, WHO Global Breast Cancer Initiative, World Health Organization

I am a medical doctor and global health physician with a 17-year career experience in cancer clinical care and policy making, program management and leadership.I joined WHO in January 2024 as the Lead, Global Breast Cancer Initiative. I also support the National Cancer Control Planning... Read More →

Dr. Susan Harvey

Curing Women’s Cancer (CWC)

Susan C. Harvey M.D. practiced breast imaging for 30 years, the last 15 years at Johns HopkinsSchool of Medicine where she led the Division of Breast Imaging from 2013 to 2019. She developed clinical excellence in care and built teaching and research programs. Her research focused... Read More →

Dr. Saraswati Sukumar

Johns Hopkins University School of Medicine

Dr. Saraswati Sukumar is a Barbara B. Rubenstein Professor of Oncology at Johns Hopkins University School of Medicine, and Professor of Pathology. Her lab is focused on using methylated gene markers to detect breast cancer. Her current clinical study in Africa is focused on the development... Read More →

Friday September 27, 2024 8:00am - 9:30am EDT
TBA

Women

Attendees (153)

Science Summit 2024

Attendees (153)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!